Table 1.
The 8 core cell lines used in this work, with their corresponding number of GESs for compounds with known structure tested at 10 μM/24 h.
| Cell line | Primary site | Subtype | Number of 10 μM−24 h signatures |
|---|---|---|---|
| A375 | Skin | Malignant melanoma | 3,525 |
| A549 | Lung | Non small cell lung cancer| carcinoma | 5,267 |
| HA1E | Kidney | Normal kidney | 3,646 |
| HCC515 | Lung | Carcinoma | 1,932 |
| HT29 | Large intestine | Colorectal adenocarcinoma | 3,192 |
| MCF7 | Breast | Adenocarcinoma | 7,546 |
| PC3 | Prostate | Adenocarcinoma | 8,071 |
| VCAP | Prostate | Carcinoma | 6,365 |